Qiagen NV
Spoorstraat 50
Venlo,
5911 KJ
Phone: 31 77 320 8400
Fax: 31 77 320 8409
Web Site: http://www.qiagen.com
| QIAGEN N.V., through its subsidiaries, engages in the development, manufacture, and marketing of products for the handling, separation, purification, and subsequent use of nucleic acids and proteins. It offers sample and assay consumable products, which include disposable sample processing devices and/or other proprietary technologies; reagents and buffers; and a technical handbook that includes a detailed protocol and background information. The company's consumable products are used in plasmid deoxyribonucleic acid purification; ribonucleic acid stabilization and purification; genomic and viral nucleic acid purification; nucleic acid transfection; PCR amplification; reverse transcription; DNA cleanup after PCR and sequencing; and DNA cloning and protein purification. The company also offers PCR assays, which allow PCR-based detection of viral, bacterial and parasite, human, and animal pathogens, as well as pharmacogenomic genotyping; and various products, including sample and assay technologies for research in the areas of epigenetics, gene expression, micro RNA, proteomics, RNAi, and molecular diagnostics. In addition, it offers BioRobot systems that offer walk-away automation of sample and assay technologies in low, medium, or high throughput scale, as well as reaction set-up and other laboratory tasks; QIAcube, which allows users in research in life sciences, applied testing, and molecular diagnostic to automate the processing of the company's consumable products; and instruments to OEM partners. Further, it provides custom services, siRNA synthesis, whole genome amplification services, DNA sequencing, and non-cGMP DNA production on a contract basis; and sells and/or licenses technology. It serves academic institutions and governmental laboratories, as well as pharmaceutical and biotechnology companies worldwide. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. |
|
| Key Statistics |
|
|
|
| |
Pay |
Exercised |
Mr. Peer M. Schatz , 42
Chairman of Management Board, Chief Exec. Officer, Sec., Treasurer, Managing Director and Chairman of Exec. Committee
|
N/A
|
N/A |
Dr. Metin Colpan PhD, 52
Co-Founder, Sr. Technology Advisor and Supervisory Director
|
N/A
|
N/A |
Prof. Dr. Detlev H. Riesner , 66
Co-Founder, Chairman Supervisory Board and Chairman of Selection and Appointment Committee
|
N/A
|
N/A |
Mr. Roland Sackers , 39
Chief Financial Officer, Managing Director and Member of Management Board
|
N/A
|
N/A |
Mr. Bernd Uder , 51
Sr. VP of Sales & Marketing, Managing Director and Member of Management Board
|
N/A
|
N/A |
|
|
|
Dollar amounts are as of
31-Dec-06
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
|
|
|
Help
Profile
